
Quest Diagnostics Incorporated Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 131 trades in Quest Diagnostics Incorporated (NYSE: DGX) since 2013, across 20 members, worth an estimated $1.9M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 64 buys against 67 sells, a modestly sell-led skew, with Democratic members responsible for 35% of the trades and Republican members 65%. The most recent disclosure shown was filed November 2026, and Rohit Khanna has filed the most DGX transactions among those shown, with 4. Other recent filers include Alan Armstrong. One notable disclosed move was a purchase by Rohit Khanna on January 29, 2026, up 43.0% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Quest Diagnostics Incorporated's current Quantellect Tide Score is 60 out of 100 (High Tide), Top 22% of universe (3865); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Quest Diagnostics Incorporated (DGX) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Quest Diagnostics congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
![]() Rohit Khanna House | Nov 5, 2026 | Oct 7, 2026 | 29 days | Sell | $1,001 - $15,000 | +14.37% | Spouse | |
![]() Rohit Khanna House | Oct 7, 2026 | Sep 4, 2026 | 33 days | Buy | $1,001 - $15,000 | +9.51% | Spouse | |
![]() Alan Armstrong Senate | Jul 21, 2026 | Mar 30, 2026 | 113 days | Buy | $1,001 - $15,000 | +32.29% | Self | |
![]() Alan Armstrong Senate | Jul 21, 2026 | Mar 27, 2026 | 116 days | Buy | $1,001 - $15,000 | +33.40% | Self | |
![]() Rohit Khanna House | Mar 9, 2026 | Feb 17, 2026 | 20 days | Sell | $1,001 - $15,000 | +26.92% | Spouse | |
![]() Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | Buy | $1,001 - $15,000 | +43.03% | Spouse |
Quest Diagnostics (DGX) congressional trading FAQ
Can members of Congress legally trade Quest Diagnostics (DGX) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Quest Diagnostics (DGX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Quest Diagnostics (DGX) trades public?
Yes. Every congressional trade in Quest Diagnostics (DGX) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Quest Diagnostics (DGX)?
Members of Congress have disclosed 131 trades in Quest Diagnostics (DGX) worth $1.9M across 20 members, according to public STOCK Act filings.
Which members of Congress have traded Quest Diagnostics (DGX)?
Recent and active filers of Quest Diagnostics (DGX) disclosures include Rohit Khanna, Alan Armstrong. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Quest Diagnostics (DGX) more?
Across disclosed Quest Diagnostics (DGX) trades, 35% were by Democrats and 65% by Republicans, led by Republicans (65%).
What is the most recent congressional Quest Diagnostics (DGX) trade?
The most recent disclosed Quest Diagnostics (DGX) filing reported a sell by Rohit Khanna, filed Nov 4, 2026.
What is Quest Diagnostics (DGX)'s Tide Score?
Quest Diagnostics (DGX) has a Quantellect Tide Score of 60 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewQuest Diagnostics (DGX) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.



